Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease.

about

Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease.

Item

http://www.wikidata.org/entity/Q41909607

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease.

@en

type

Item

label

Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease.

@en

prefLabel

Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease.

@en

P1476

Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease.

@en

P2093

Azmi Shahbari

http://www.w3.org/2001/XMLSchema#string

Elchanan Nussinson

http://www.w3.org/2001/XMLSchema#string

Fahmi Shibli

http://www.w3.org/2001/XMLSchema#string

Irit Elmalah

http://www.w3.org/2001/XMLSchema#string

Mazen Elias

http://www.w3.org/2001/XMLSchema#string

Wasseem Rock

http://www.w3.org/2001/XMLSchema#string

P2860

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Primary effusion lymphoma

EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.

Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.

Update on HHV-8-Associated Malignancies

KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states

The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies.

Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?

Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low

Risk of haematopoietic cancer in patients with inflammatory bowel disease.

P304

857-862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.3748/WJG.V20.I3.857

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260396979

http://www.w3.org/2001/XMLSchema#string

P698

24574759

http://www.w3.org/2001/XMLSchema#string

P932

3921495

http://www.w3.org/2001/XMLSchema#string